Cancer Therapy Vol 3, 185-188, 2005
Radical parametrectomy in the treatment of invasive cervical
cancer after simple hysterectomy
Nadereh Behtash1,*, Haleh Ayatollahi1,
Fatemeh Ghaemmaghami1,Malihe Hasanzadeh, Fatemeh Esfehani2
1Gynecology
Oncology, Tehran University of Medical Sciences, Tehran, Iran.
2Epidemiology,
Tehran University of Medical Sciences, Tehran, Iran.
__________________________________________________________________________________
*Correspondence: Nadereh
Behtash, Associate Professor, Tehran University of Medical Sciences. Gynecology
Oncology Department, Vali-e-Asr Hospital, Keshavarz Blvd., Tehran 14194, Iran.
Phone: #98-21-6939320, Fax: #98-21-6937321, E-mail: nadbehtash@yahoo.com
Key words: Radical
Parametrectomy, Invasive cervical cancer
Abbreviations:
neoadjuvant chemotherapy, (NACT); radical parametrectomy (RP)
Summary
To assess
the morbidity and efficacy of radical parametrectomy (RP) following simple
hysterectomy in patients with invasive cervical carcinoma. Seven year
retrospective chart review identified 5 patients that underwent RP with pelvic
and paraaortic lymphadenectomy and upper vaginectomy. Data were collected on
demographics, tumor stage, histology and survival. One patient had stage IA
lesion, one stage IB1, 2patients had stage IIA, and one
with unknown stage. One of these patients had adenocarcinoma. Median age was
41.6 years. The most indication for hysterectomy was abnormal vaginal bleeding
(3 out of 5, 60%). Two patients had pelvic node metastases. Surgical margins in
all 5 patients were tumor free at the time of RP. Two patients with positive
pelvic nodes received adjuvant radiotherapy. Mean follow up time was 48.8
months. Four patients are alive without disease, and one patient who had been
node positive, died 12 months after receiving radiation. RP is an acceptable
option for patients diagnosed with incidental finding of invasive cervical
cancer at the time of simple hysterectomy. Careful selection of RP for patients
not having residual tumor, will obviate adjuvant radiotherapy in most cases.
I. Introduction
The management of early stage cervical carcinoma is
primarily surgical in the majority of patients. Invasive cervical carcinoma
after simple hysterectomy, can be treated with radiotherapy or reoperation
involving a pelvic and/or paraaortic lymphadenectomy, radical Parametrectomy,
and upper vaginectomy (Orr et al, 1986; Hopkins et al, 1990; Chapman et al,
1992; Roman et al, 1993; Crane and Schneider, 1999).
Since radiation therapy results in loss of ovarian
function and greater frequency of sexual dysfunction than operative techniques,
RP seems more beneficial option. It can be performed safely in most patients,
who have an early stage invasive carcinoma of the cervix with the expectation
of an acceptable rate of long term disease free survival (Kinney et al, 1992).
Due to inadequate screening and diagnostic work up, we have frequent cases of
cervical carcinoma as incidental finding in simple hysterectomy specimen
(Behtash et al, 2003).
Overall survival in cervical carcinoma treated with
simple hysterectomy is less than 50% at 5 years (Jones and Jones, 1943; Daniel
and Brunschwig, 1961; Barber et al, 1968). Additional therapy in these patients
include radiation therapy (Cosbie, 1963; Green Jr and Morse Jr, 1969; Andras et
al, 1973; Davy et al, 1977; Papavasiliou et al, 1980; Perkins et al, 1984;
Behtash et al, 2003), or additional surgery (Barber et al, 1968; Green Jr and
Morse Jr, 1969; Orr et al, 1986; Chapman et al, 1992; Kinney et al, 1992;
Behtash et al, 2003).
Described in 1961 by Daniel and Brunschwig, RP is a
surgical procedure that allows one to complete the evaluation of the tissues of
concern, namely upper vagina, parametrium and the regional lymphatics.
The objective of our study is to evaluate the
morbidity and efficacy of RP in patients with cervical carcinoma in their
simple hysterectomy specimen.
II. Materials and methods
A retrospective chart review
identified 150 patients with early stage cervical carcinomas (FIGO stage IA-IIA)
treated at Vali-e-Asr University Hospital of Tehran University of Medical
Sciences, Tehran, Iran from 1997-2003.
Five of these patients were
evaluated for RP secondary to the diagnosis of invasive cervical cancer in
cervical specimen following simple hysterectomy. To be considered eligible for
RP patients were required to have a normal pelvic exam before surgery with no
evidence of residual disease in the parametrium (stage IA-IIA). RP was
performed on 2 months, 4months, 4months, 18 months, and 10 years after simple
hysterectomy.
Clinicopathologic information
including demographics, indication for hysterectomy, tumor stage, histology,
nodal status, operative complications, length of stay, recurrence and survival
was collected. One patient had subtotal hysterectomy in the first procedure.
Follow up data were obtained by review of the medical records or by the patient
correspondence.
III. Results
Two patients had stage IIA lesions; one
patient had stage IB1; one patient IA2 and one stage IB2.
Demographic information is listed in Tables
1 and 2.
Four patients underwent RP, upper vaginectomy, pelvic
and/or paraaortic lymphadenectomy, and the fifth one had an additional
cervicectomy due to previous subtotal hysterectomy. Median number of dissected
pelvic lymph nodes was 12.
We had no major operative and post operative
complications. Mean post operative length of stay was 5 days.
Two patients had cuff biopsy (large cell
non-keratinizing SCC) in preoperative evaluation. They received 3 courses of
neoadjuvant chemotherapy (NACT) before operation (RP).
Table 1.
|
|
Mean |
Range |
|
Age |
41.6 |
35-47 |
|
Gravidity |
4.75 |
1-9 |
|
Para |
3.7 |
1-6 |
|
Menarche |
12.5 |
12-13 |
|
First intercourse |
15.75 |
12-21 |
Table 2.
|
|
Number of patients |
|
|
Stage |
IA2 |
1 |
|
IB1 |
1 |
|
|
IB2 |
1 |
|
|
IIA |
2 |
|
|
Pathology |
SCC |
4 |
|
Adenocarcinoma |
1 |
|
|
Indications for simple hysterectomy |
CIN |
2 |
|
Abnormal
uterine bleeding |
3 |
|
Chemotherapy treatment consisted of Cisplatinum 20
mg/q 10 days/ for 3 courses, Vincristine 1 mg/q 10 days/ for 3 courses.
After radical surgery, both of these patients had
positive lymph nodes in pelvis, residual tumor in vaginal specimen with clear
margins. They received post operative external beam radiotherapy (6800-7000
cGy). One of these patients is alive without disease after 89 months. But the
other one died about 15 months after completing adjuvant radiotherapy with
progressive disease.
Two patients (stage IA2, IB1)
had no residual disease in preoperative and pathologic evaluation following RP.
Although one of these two patients, in preoperative colposcopic exam, showed moderate dysplasia in cuff.
Both of these patients are alive without disease in 65
months and 23 months follow up. One patient, who underwent subtotal
hysterectomy due to abnormal vaginal bleeding, had stage IB2 adenocarcinoma of
cervix and received 5400 cGy external radiotherapy before RP. After 6 weeks,
she underwent radical cervicectomy plus RP plus upper vaginectomy plus pelvic
and paraaortic lymphadenectomy. She had no residual tumor in pathologic
specimens, and is alive without disease 48 months after radical surgery.
Overall, the 5 year survival for our patients with
completed RP is 80% with a median follow up of 48 months. With a median follow
up of 48 months (17-89) four patients are still alive without disease (23, 48,
65, and 89 months). One patient died due to progressive disease at 17 months
after surgery.
IV. Discussion
Incidental finding of cervical carcinoma is rather
frequent following simple hysterectomy for apparently benign diseases. In our
series, the most common primary diagnosis was CIN and abnormal uterine
bleeding. Based on our previous study, inadequate preoperative (pre-hysterectomy)
evaluation for patients with abnormal Pap-smear and vaginal bleeding, were the
main reasons of inappropriate management (Behtash et al, 2003). Unfortunately,
in our series (Behtash et al, 2003), even patients with biopsy proven SCC of
cervix underwent simple hysterectomy, although even adequate preoperative
evaluation could not find occult cervical carcinoma. Simple hysterectomy is
considered to be adequate surgery only for patients with microinvasion (stage
IA1) (Jones and Jones, 1943; Daniel and Brunschwig, 1961; Barber et al, 1968).
Additional treatment for more invasive carcinoma
finding after simple hysterectomy is radiation therapy with or without
chemotherapy or RP with lymphadenectomy.
In appropriate candidates, it seems radical
reoperation, especially in a young patient, allows ovarian preservation and
functional vagina (Orr et al, 1986; Chapman et al, 1992; Kinney et al, 1992).
Selection of an eligible patient for RP is critical.
Leath III, et al, (2004) showed patients with no clinical evidence of residual
at the vaginal apex and parametrium have an excellent overall survival. They
had a rather high operative morbidity (30%) including 2 incidental cystectomy
and massive transfusion in 4 patients. In other series, there are rate of
morbidity following RP (Orr et al, 1986; Chapman et al, 1992; Kinney et al,
1992). We had no massive transfusion, no major surgical or postoperative
morbidity in these five patients.
In a study Leath III et al, (2004), the length of
hospital stay was 3.6 days, which is much shorter than our series, although
different insurance problems in two countries may influence this point.
Postoperative adjuvant radiotherapy may increase
morbidity dramatically, which has been reported in radical hysterectomy
(Martimbeau et al, 1978; Barter et al, 1989; Fiorica et al, 1990).
We planned NACT before radical surgery in two patients
with disease in central culf, to minimize the likelihood of postoperative
radiotherapy. Due to positive pelvic node and residual tumor in vaginal specimen
(with clear margin), they received adjuvant radiotherapy. As Orr et al, (1986)
noted the decision for planning radiation can only be made after surgery. Four
largest series that evaluated RP in the management of cervical cancer included
18-27 patients (RP (Orr et al, 1986; Chapman et al, 1992; Kinney et al, 1992;
Leath III et al, 2004). Seventeen patients out of 23 in Orr series (Orr et al,
1986) had negative RP specimen and all were with no evidence of recurrence with
a modest 36 month follow up. With a median follow up of 72 months, Chapman et
al (1992) reported 89% five year survival. Their study also confirmed that
extended survival can be obtained in patients with a negative RP specimen.
Furthermore, the absence of long term morbidities, such as urinary fistula, was
encouraging.
Kinney et al, (1992) reported 82% survival with a
median follow up of 8.4 years. In their series, all the recurrences occurred
within 4 years.
The incidence of positive nodes in these four large
series was 10% (9/93), while the incidence of positive vaginal margin or
positive parametrium is 7% (7/93). Eighty percent of patients were able to have
a completed RP without evidence of residual disease.
Cosbie, (1963) reported 116 patients with cervical
cancer over 3 decades that received radiotherapy following simple hysterectomy.
In spite of 16 patients with microinvasive disease, their 5 year survival rate
was only 71%.
Green and Morse, (1969) evaluated outcome of 84
patients that received either surgery or radiation following extrafacial or
subtotal hysterectomy in cervical cancer. Five year overall survival in
radiation group was 30% while 67% in radical operation patients. Importantly, the authors demonstrated
that a delay in further therapy of greater than 4 months was associated with an
overall 5 year survival of 18% as compared to 42% when patients were treated
within 4 months (Andras et al, 1973; Davy et al, 1977).
Survival data from the University of Virginia
utilizing radiation therapy were 93% at 5 years (Crane and Schneider, 1999).
However, 12/18 patients suffered either grade 1 or 2
acute toxicities and 2 had long term complications consisting of chronic
diarrhea and small bowel obstruction that necessitated surgical exploration.
Survival statistics in these series may be influenced by inclusion of patients
with higher risk factors such as large diameter tumors, tumors at the cervical
margin or involving the parametrium and/or vagina and nodal metastasis.
Although radiotherapy is quite effective for patientsŐ
early invasive carcinoma of cervix after simple hysterectomy, its serious
potential morbidity and costs should be considered.
In our country, long waiting list for radiotherapy,
frequent cases of inappropriately managed, common incidence of cervical
carcinoma are additional reasons
that make RP as an acceptable and safe alternative for carefully selected
patients. To our knowledge this is the first report of radical parametrectomy
in our country.
Andras EJ,
Fletcher GH, Rutledge F (1973)
Radiotherapy of carcinoma of the cervix following simple hysterectomy. Am J Obstet Gynecol 115, 647-55.
Barber HR,
Pece GV, Brunschwig A (1968)
Operative management of patients previously operated upon for a benign lesion
with cervical cancer as surprise finding. Am
J Obstet Gynecol 101, 959-65.
Barter JF,
Soong SJ, Shingleton HM, Hatch KD, Orr Jr JW (1989) Complications of combined radical hysterectomy- postoperative
radiation therapy in women with early stage cervical cancer. Gynecol Oncol 32, 292-6.
Behtash N,
Mousavi A, Mohit M, Modares M, Khanafshar N, Hanjani P (2003) Simple hysterectomy in the presence of invasive cervical
cancer in Iran. Int J Gynecol Cancer
13, 177-81.
Chapman JA,
Mannel RS, Disaia PJ, Walker JL, Berman ML (1992) Surgical treatment of unexpected invasive cervical cancer
found at total hysterectomy. Obstet
Gynecol 80, 931-4.
Cosbie W (1963) Radiotherapy following
hysterectomy performed for or in the presence of cancer of the cervix. Am J Obstet Gynecol 85, 332-7.
Crane CH,
Schneider BF (1999) Occult carcinoma
discovered after simple hysterectomy treated with postoperative radiotherapy. Int J Radiot Oncolo Biol Phys 43, 1049-53.
Daniel W,
Brunschwig A (1961) The management
of recurrent carcinoma of cervix following simple total hysterectomy. Cancer 14, 582-6.
Davy M,
Bentzen H, Jahren R (1977) Simple
hysterectomy in the presence of invasive cervical cancer. Acta Obstet Gynecol Scand 56, 105-8.
Fiorica JV,
Roberts WS, Greeberg H, Hoffman MS, Lapolla JP, Cavangh D (1990) Morbidity and survival patterns in patients after radical
hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 36, 343-7.
Green TH Jr,
Morse WJ Jr (1969) Management of
invasive cervical cancer following inadvertent simple hysterectomy. Obstet Gynecol 33, 763-9.
Hopkins MP,
Peters WAIII, Anderson W, Morley GW (1990)
Invasive cervical cancer treated initially by standard hysterectomy. Gynecol Oncol 36, 7-12.
Jones H, Jones
G (1943) Panhysterectomy versus
irradiation in early cancer of cervix. JAMA
122, 930-2.
Kinney WK,
Egorshin EU, Ballard DJ, Podratz KC (1992)
Long term survival and sequelae after surgical management of invasive cervical
carcinoma diagnosed at the time of simple hysterectomy. Gynecol Oncol 44, 24-7.
Leath III CA,
Straughn Jr JM, Bhoola Snehal M, Patridge EE et al (2004) The role of radical Parametrectomy in the treatment of occult
cervical carcinoma after extrafascial hysterectomy. Gynecol Oncol 92, 215-19.
Martimbeau PW,
kjorstad KE, Kolstad P (1978) Stage
IB carcinoma of the cervix, the Norwegian Radium Hospital,
1968-1970, results of treatment and major complications, Lymphedema. Am J Obstet Gynecol 131, 389-94.
Orr JW, Ball
GC, Soong SJ, Hatch KD, Partridge EE, Austin JM (1986) Surgical treatment of women found to have invasive cervix
cancer at the time of total hysterectomy. Obstet
Gynecol 68, 353-6.
Papavasiliou
C, Yiogarakis D, Pappaskeramopoulos A (1980)
Treatment of cervical carcinoma by total hysterectomy and post operative
external irradiation. Int J Radiot Oncol
biol Phys 6, 871-4.
Perkins PL,
Chu AM, Jose B, Achino E, Tobin DA (1984)
Posthysterectomy mega voltage irradiation in the treatment of cervical
carcinoma. Gynecol Oncol 17, 340-8.
Roman LD, Morris M, Mitchell MF, Eifel PJ, Burke TW, Atkinson EN (1993) Prognostic factor for patients
undergoing simple hysterectomy in the presence of invasive cancer of cervix. Gynecol Oncol 50, 179-83.